MoneyWorks4Me

Aurobindo Pharma board to consider Un-Audited Financial Results

22 Jan 2014 Evaluate

Aurobindo Pharma has informed that a meeting of the Board of Directors of the Company will be held on February 06, 2014, to consider the Un-Audited Financial Results of the Company for the quarter ended December 31, 2013 (Q3).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..